Sponsor or institution
Clinical trials and research at Academic and Community Cancer Research United
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Academic and Community Cancer Research United that are recruiting, in United States. By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Epcoritamab for B-cell lymphoma patients not fully responding to CAR-T therapy | Phase 2 | Rochester, Minnesota and 5 other locations | Recruiting | Feb 2, 2024 |
| Combining retifanlimab, bevacizumab, and radiation for recurrent glioblastoma treatment | Phase 2 | Scottsdale, Arizona and 2 other locations | Recruiting | Dec 7, 2023 |
| Combination treatment for relapsed or refractory mantle cell lymphoma | Phase 2 | Rochester, Minnesota and 1 other locations | Recruiting | Jun 20, 2023 |
| Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment | Phase 2 | Scottsdale, Arizona and 15 other locations | Recruiting | Dec 23, 2021 |
All recruiting trials (4)
-
Epcoritamab for B-cell lymphoma patients not fully responding to CAR-T therapy
This study is testing if a new treatment called epcoritamab can help people with B-cell lymphoma who didn't fully respond to CAR-T therapy feel better and improve their chances of survival.
-
Combining retifanlimab, bevacizumab, and radiation for recurrent glioblastoma treatment
This study is testing whether a new combination of a drug and radiation can help people with recurring glioblastoma live longer and feel better compared to just using one of the drugs with radiation.
-
Combination treatment for relapsed or refractory mantle cell lymphoma
This study is testing a new combination of three drugs to see if it can help people with relapsed or refractory mantle cell lymphoma feel better and live longer.
-
Combining atezolizumab with a multi-kinase inhibitor for advanced liver cancer treatment
This study is testing if adding atezolizumab to either cabozantinib or lenvatinib can help people with advanced liver cancer live longer and feel better compared to just taking the multi-kinase inhibitor alone.
Quick answers
How many clinical trials run by Academic and Community Cancer Research United are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.